SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Attiga FA, Fernandez PM, Weeraratna AT, Manyak MJ, Patierno SR. 2000. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res 60: 46294637.
  • Belley A, Chadee K. 1999. Prostaglandin E(2) stimulates rat and human colonic mucin exocytosis via the EP(4) receptor. Gastroenterology 117: 13521362.
  • Belvisi MG, Saunders M, Yacoub M, Mitchell JA. 1998. Expression of cyclo-oxygenase-2 in human airway smooth muscle is associated with profound reductions in cell growth. Br J Pharmacol 125: 11021108.
  • Bornfeldt KE, Campbell JS, Koyama H, Argast GM, Leslie CC, Raines EW, Krebs EG, Ross R. 1997. The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. J Clin Invest 100: 875885.
  • Breyer RM, Bagdassarian CK, Myers SA, Breyer MD. 2001. Prostanoid receptors: Subtypes and signaling. Annu Rev Pharmacol Toxicol 41: 661690.
  • Cao Y, Traer E, Zimmerman GA, McIntyre TM, Prescott SM. 1998. Cloning, expression, and chromosomal localization of human long-chain fatty acid-CoA ligase 4 (FACL4). Genomics 49: 327330.
  • Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM. 2000. Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci U S A 97: 1128011285.
  • Chan TA, Morin PJ, Vogelstein B, Kinzler KW. 1998. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A 95: 681686.
  • Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, Edelstein D, Soslow RA, Koki AT, Woerner BM, Masferrer JL, Dannenberg AJ. 1999. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59: 991994.
  • Chang YW, Jakobi R, McGinty A, Foschi M, Dunn MJ, Sorokin A. 2000. Cyclooxygenase-2 promotes cell survival by stimulation of dynein light chain expression and inhibition of neuronal nitric oxide synthase activity. Mol Cell Biol 20: 85718579.
  • Chen JK, Capdevila J, Harris RC. 2001a. Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis. Mol Cell Biol 21: 63226331.
  • Chen WS, Wei SJ, Liu JM, Hsiao M, Kou-Lin J, Yang WK. 2001b. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac. Int J Cancer 91: 894899.
  • Chulada PC, Thompson MB, Mahler JF, Doyle CM, Gaul BW, Lee C, Tiano HF, Morham SG, Smithies O, Langenbach R. 2000. Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res 60: 47054708.
  • Coffey RJ, Hawkey CJ, Damstrup L, Graves-Deal R, Daniel VC, Dempsey PJ, Chinery R, Kirkland SC, DuBois RN, Jetton TL, Morrow JD. 1997. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A 94: 657662.
  • Daniel TO, Liu H, Morrow JD, Crews BC, Marnett LJ. 1999. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 59: 45744577.
  • Dbaibo G, Obeid LM, Hannun YA. 1993. Tumor necrosis factor-alpha (TNF-α) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-α from activation of nuclear factor-kappa B. J Biol Chem 268: 1776217766.
  • Dermott JM, Reddy MR, Onesime D, Reddy EP, Dhanasekaran N. 1999. Oncogenic mutant of Galpha12 stimulates cell proliferation through cycloxygenase-2 signaling pathway. Oncogene 18: 71857189.
  • Dimberg J, Hugander A, Sirsjo A, Soderkvist P. 2001. Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer. Anticancer Res 21: 911915.
  • Ding XZ, Tong WG, Adrian TE. 2000. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Res 20: 26252631.
  • Dohadwala M, Luo J, Zhu L, Lin Y, Dougherty GJ, Sharma S, Huang M, Pold M, Batra RK, Dubinett SM. 2001. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J Biol Chem 276: 2080920812.
  • Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE. 1998. Cyclooxygenase in biology and disease. FASEB J 12: 10631073.
  • Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. 1994. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 11831188.
  • Fonteh AN, LaPorte T, Swan D, McAlexander MA. 2001. A decrease in remodeling accounts for the accumulation of arachidonic acid in murine mast cells undergoing apoptosis. J Biol Chem 276: 14391449.
  • Gately S. 2000. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 19: 1927.
  • Grilli M, Pizzi M, Memo M, Spano P. 1996. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274: 13831385.
  • Grossman EM, Longo WE, Panesar N, Mazuski JE, Kaminski DL. 2000. The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells. Carcinogenesis 21: 14031409.
  • Gupta RA, DuBois RN. 2000. Translational studies on Cox-2 inhibitors in the prevention and treatment of colon cancer. Ann N Y Acad Sci 910: 196206 (discussion).
  • Handler JA, Danilowicz RM, Eling TE. 1990. Mitogenic signaling by epidermal growth factor (EGF), but not platelet-derived growth factor, requires arachidonci acid metabolism in BALB/c 3T3 cells. Modulation of EGF-dependent c-myc expression by prostaglandins. J Biol Chem 265: 36693673.
  • Hida T, Kozaki K, Muramatsu H, Masuda A, Shimizu S, Mitsudomi T, Sugiura T, Ogawa M, Takahashi T. 2000. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res 6: 20062011.
  • Higashi Y, Kanekura T, Kanzaki T. 2000. Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: Evidence for growth suppression by inhibiting COX-2 expression. Int J Cancer 86: 667671.
  • Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241251.
  • Howe LR, Crawford HC, Subbaramaiah K, Hassell JA, Dannenberg AJ, Brown AM. 2001. PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2. J Biol Chem 276: 2010820115.
  • Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM, Chen CS. 2000. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 275: 1139711403.
  • Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA. 2000. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res 60: 50405044.
  • Jiang MC, Liao CF, Lee PH. 2001. Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells. Biochem Biophys Res Commun 282: 671677.
  • Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK, Seyfried NT, Abe T, Chen LB, Carroll RS, Black PM. 2000. Expression of cyclooxygenase-2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60: 49264931.
  • Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS. 1999. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing [see comments]. Nat Med 5: 14181423.
  • Kimura M, Osumi S, Ogihara M. 2000. Stimulation of DNA synthesis and proliferation by prostaglandins in primary cultures of adult rat hepatocytes. Eur J Pharmacol 404: 259271.
  • Konger RL, Malaviya R, Pentland AP. 1998. Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes. Biochim Biophys Acta 1401: 221234.
  • Kopp E, Ghosh S. 1994. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265: 956959.
  • Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, Zimmerman GA, White RL, Prescott SM. 1996. Prostaglandin H synthase-2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc Natl Acad Sci U S A 93: 48164820.
  • Li M, Wu X, Xu XC. 2001. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Clin Cancer Res 7: 10101016.
  • Liu XH, Yao S, Kirschenbaum A, Levine AC. 1998. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res 58: 42454249.
  • Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, Haudenschild C, Lane TF, Hla T. 2001. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 276: 1856318569.
  • Lu X, Xie W, Reed D, Bradshaw WS, Simmons DL. 1995. Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc Natl Acad Sci U S A 92: 79617965.
  • Mann M, Sheng H, Shao J, Williams CS, Pisacane PI, Sliwkowski MX, DuBois RN. 2001. Targeting cyclooxygenase-2 and HER-2/neu pathways inhibits colorectal carcinoma growth. Gastroenterology 120: 17131719.
  • Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K. 2000. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60: 13061311.
  • Matsuura H, Sakaue M, Subbaramaiah K, Kamitani H, Eling TE, Dannenberg AJ, Tanabe T, Inoue H, Arata J, Jetten AM. 1999. Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases. J Biol Chem 274: 2913829148.
  • McGinty A, Chang YW, Sorokin A, Bokemeyer D, Dunn MJ. 2000. Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells. J Biol Chem 275: 1209512101.
  • Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope FA. 1999. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res 59: 43564362.
  • Neufang G, Furstenberger G, Heidt M, Marks F, Muller-Decker K. 2001. Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin. Proc Natl Acad Sci U S A 98: 76297634.
  • Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. 1995. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci U S A 92: 44824486.
  • Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM. 1996. Suppression of intestinal polyposis in ApcD716 knockout mice by inhibition of prostaglandin endoperoxide synthase-2 (COX-2). Cell 87: 803809.
  • Oshima M, Murai N, Kargman S, Arguello M, Luk P, Kwong E, Taketo MM, Evans JF. 2001. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 61: 17331740.
  • Piazza GA, Rahm ALK, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS, Pamukcu R, Ahnen DJ. 1995. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 55: 31103116.
  • Poligone B, Baldwin AS. 2001. Positive and negative regulation of NF-kappaB by COX-2: Roles of different prostaglandins. J Biol Chem 16: 16.
  • Prescott SM, White RL. 1996. Self promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell 87: 783786.
  • Ratnasinghe D, Tangrea J, Roth MJ, Dawsey S, Hu N, Anver M, Wang QH, Taylor PR. 1999. Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus: An immunohistochemical survey. Anticancer Res 19: 171174.
  • Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV. 2000. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res 60: 293297.
  • Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, Santoro MG. 2000. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403: 103108.
  • Rozic JG, Chakraborty C, Lala PK. 2001. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int J Cancer 93: 497506.
  • Rudnick DA, Perlmutter DH, Muglia LJ. 2001. Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Proc Natl Acad Sci U S A 98: 88858890.
  • Scorrano L, Penzo D, Petronilli V, Pagano F, Bernardi P. 2001. Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha aopototic signaling. J Biol Chem 276: 1203512040.
  • Segi E, Sugimoto Y, Yamasaki A, Aze Y, Oida H, Nishimura T, Murata T, Matsuoka T, Ushikubi F, Hirose M, Tanaka T, Yoshida N, Narumiya S, Ichikawa A. 1998. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys Res Commun 246: 712.
  • Shao J, Sheng H, Inoue H, Morrow JD, DuBois RN. 2000. Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J Biol Chem 275: 3395133956.
  • Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN. 1997. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99: 22542259.
  • Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. 1998. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58: 362366.
  • Sheng H, Shao J, Washington MK, DuBois RN. 2001. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276: 1807518081.
  • Smith WL, Garavito RM, DeWitt DL. 1996. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271: 3315733160.
  • Sonoshita M, Takaku K, Sasaki N, Sugimoto Y, Ushikubi F, Narumiya S, Oshima M, Taketo MM. 2001. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcDelta716 knockout mice. Nat Med 7: 10481051.
  • Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ. 2000. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res 60: 57675772.
  • Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B. 2000. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342: 19461952.
  • Stock JL, Shinjo K, Burkhardt J, Roach M, Taniguchi K, Ishikawa T, Kim HS, Flannery PJ, Coffman TM, McNeish JD, Audoly LP. 2001. The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. J Clin Invest 107: 325331.
  • Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, Glass CK. 2000. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappaB signaling pathway. Proc Natl Acad Sci U S A 97: 48444849.
  • Subbaramaiah K, Zakim D, Weksler BB, Dannenberg AJ. 1997. Inhibition of cyclooxygenase: A novel approach to cancer prevention. Proc Soc Exp Biol Med 216: 201210.
  • Sundy JS. 2001. Cox-2 inhibitors in rheumatoid arthritis. Curr Rheumatol Rep 3: 8691.
  • Surette ME, Winkler JD, Fonteh AN, Chilton FH. 1996. Relationship between arachidonate–phospholipid remodeling and apoptosis. Biochemistry 35: 91879196.
  • Surette ME, Fonteh AN, Bernatchez C, Chilton FH. 1999. Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells. Carcinogenesis 20: 757763.
  • Takafuji V, Cosme R, Lublin D, Lynch K, Roche JK. 2000. Prostanoid receptors in intestinal epithelium: Selective expression, function, and change with inflammation. Prostaglandins Leukot Essent Fatty Acids 63: 223235.
  • Taketo MM. 1998. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J Natl Cancer Inst 90: 16091620.
  • Tessner TG, Cohn SM, Schloemann S, Stenson WF. 1998. Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice. Gastroenterology 115: 874882.
  • Tsuji S, Kawano S, Sawaoka H, Takei Y, Kobayashi I, Nagano K, Fusamoto H, Kamada T. 1996. Evidence for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostaglandins Leukot Essent Fatty Acids 55: 179183.
  • Tsujii M, Dubois RN. 1995. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493501.
  • Tsujii M, Kawano S, DuBois RN. 1997. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A 94: 33363340.
  • Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. 1998. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705716.
  • Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT, Fahey TJ III. 1999. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 59: 987990.
  • Uefuji K, Ichikura T, Shinomiya N, Mochizuki H. 2000. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines. Anticancer Res 20: 42794284.
  • Ushikubi F, Segi E, Sugimoto Y, Murata T, Matsuoka T, Kobayashi T, Hizaki H, Tuboi K, Katsuyama M, Ichikawa A, Tanaka T, Yoshida N, Narumiya S. 1998. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395: 281284.
  • Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A. 1998. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58: 49975001.
  • Yamamoto Y, Yin MJ, Lin KM, Gaynor RB. 1999. Sulindac inhibits activation of the NF-kappaB pathway. J Biol Chem 274: 2730727314.
  • Yin MJ, Yamamoto Y, Gaynor RB. 1998. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396: 7780.
  • Zhang X, Morham SG, Langenbach R, Young DA. 1999. Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J Exp Med 190: 451459.